1 Molecular Cancer Therapeutics Abstract

[pyrazole]

1
Abstract B64: Structure and preclinical characterization of BMN 673, a potent and orally active PARP inhibitor as an anticancer agent.
Yuqiao Shen1, Ying Feng1, Bing Wang1, Peter Myers1, Daniel Chu1 and Leonard E. Post1
Molecular Cancer Therapeutics November 2011; Volume 10, Issue 11, Supplement 1
DOI:

Код: Выделить всё

10.1158/1535-7163.TARG-11-B64

Код: Выделить всё

http://mct.aacrjournals.org/cgi/content/meeting_abstract/10/11_MeetingAbstracts/B64